REG - ReNeuron Group plc - Notification of Major Interest in Shares <Origin Href="QuoteRef">RQE.L</Origin>

ReNeuronAnnouncement

28/08/2015 14:50

RNS Number : 4971X
ReNeuron Group plc
28 August 2015

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES


1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ReNeuron Group plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify): Change to notifiable interest following share issue. 
3. Full name of person(s) subject to the
notification obligation:
Abingworth LLP
Abingworth Bioventures VI LP
Abingworth Bioequities Master Fund Limited
4. Full name of shareholder(s)
(if different from 3.):
State Street Nominees Limited (as nominee for Abingworth Bioventures VI LP). 
Jefferies & Co Inc. (as nominee for Abingworth Bioequities Master Fund Limited). 
5. Date of the transaction and date on
which the threshold is crossed or
reached:
25 August 2015
6. Date on which issuer notified:
28 August 2015
7. Threshold(s) that is/are crossed or
reached: 
Below 3% threshold - Abingworth LLP and Abingworth Bioequities Master Fund Limited.


8. Notified details: Abingworth LLP
A: Voting rights attached to shares
Class/type of
shares

if possible using
the ISIN CODE
Situation previous
to the triggering
transaction
Resulting situation after the triggering transaction
Number
of
Shares
Number
of
Voting
Rights
Number
of shares
Number of voting
rights
% of voting rights 
Direct
Direct 
Indirect 
Direct
Indirect
GB00B0DZML60

94,400,000


94,400,000

2.99%


B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument
Expiration
date 
Exercise/
Conversion Period
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
% of voting
rights






C: Financial Instruments with similar economic effect to Qualifying Financial Instruments 
Resulting situation after the triggering transaction
Type of financial
instrument
Exercise price
Expiration date 
Exercise/
Conversion period 
Number of voting rights instrument refers to
% of voting rights 




Nominal
Delta



Total (A+B+C)
Number of voting rights
Percentage of voting rights
94,400,000
2.99%


8. Notified details: Abingworth Bioequities Master Fund Limited
A: Voting rights attached to shares
Class/type of
shares

if possible using
the ISIN CODE
Situation previous
to the triggering
transaction
Resulting situation after the triggering transaction
Number
of
Shares
Number
of
Voting
Rights
Number
of shares
Number of voting
rights
% of voting rights 
Direct
Direct 
Indirect 
Direct
Indirect
GB00B0DZML60
83,652,000
83,652,000
83,652,000
83,652,000


2.65%


B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument
Expiration
date 
Exercise/
Conversion Period
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
% of voting
rights






C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument
Exercise price
Expiration date
Exercise/
Conversion period 
Number of voting rights instrument refers to
% of voting rights 




Nominal
Delta



Total (A+B+C)
Number of voting rights
Percentage of voting rights
83,652,000
2.65%


9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
Abingworth Bioventures VI LP (which holds 10,748,000 shares in the company (0.34%)) and Abingworth Bioequities Master Fund Limited (which holds 83,652,000 shares in the company (2.65%)) are both managed by Abingworth LLP.

Proxy Voting:
10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease
to hold:

12. Date on which proxy holder will cease to hold
voting rights:



13. Additional information:


14. Contact name:
John Heard
15. Contact telephone number:
020 7534 1500

This information is provided by RNS
The company news service from the London Stock Exchange
  END
HOLPGUAWRUPAGWR